Peanut Allergy Trends: Rates Drop 43% in Young Children
New data shows a sharp decline in peanut allergies among children under three, linked to earlier food introduction, while experts discuss intimacy and clinical trials for older adults.
By Eric Collins ·

Peanut allergy rates in children under age 3 have dropped by roughly 43% over the last decade. This statistic comes from a study released in October 2025. The decline coincides with new research on how infants are introduced to peanut products.
The long-standing medical advice told parents to avoid peanut products for young children. New studies indicate that this approach may have been wrong. Researchers now suggest that introducing peanut products to infants between 4 and 6 months old can reduce the risk of developing an allergy.
Sam Cradduck, a gerontologist, addressed the physical and emotional impacts of aging on intimacy. She stated that the first step for couples is figuring out what is behind a change in their sex life. Competence and consent are the primary factors to consider, according to Cradduck. For physical issues such as erectile dysfunction, a doctor can often provide help.
Dr. Rhea Rogers, a board-certified physician, noted that couples often treat intimacy and sexuality as interchangeable. She said this is one of the biggest misconceptions in the field. Rogers explained that these two concepts are not the same. Understanding the difference helps couples navigate health changes related to age or illness.
Older adults are frequently underrepresented in clinical trials. Experts on the Aging Untold program suggest that participation can be a proactive way to explore new treatments. When considering a trial, Rogers said the first step is to determine what the study is trying to answer. Many people view clinical trials as a last resort, but Rogers cited access as a major benefit.
Rogers stated that participants get great access to tomorrow’s medicines today. This includes devices, therapies, and other treatments that will not be available to the general public for years. She emphasized that this early access is a key advantage of enrolling in a study.
Amy O’Rourke, an aging expert, added that participants should know they might receive a placebo. She advised that people going into a trial must understand this possibility. This information is part of the standard disclosure process for clinical research.
Flo Meiler, a 91-year-old woman from Vermont, holds two world records in track and field. Her home is filled with medals from her competitions. She started competing at age 60 and remains active. Meiler said she is sad she cannot jump like she used to, but she still enjoys the sport.
Source: KAUU






